InsidersTradesSigma
Follow the 알테오젠 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 알테오젠 has recorded 2 public disclosures. Market capitalisation: €16,748.7bn. The latest transaction was reported on 7 April 2026 (Sale). Among the most active insiders: 박순재. All data is openly available.
2
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
1 ops.
Sell Volume
2Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 5,996 of 29,064 companies
66.4
score / 100
Value40
Quality93
FCF yld0.5%
Earn yld0.8%
EV/EBITDA·
ROE25%
Gross mgn77%
Net mgn66%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 7 April 2026
Acerca de 알테오젠
Alteogen es una empresa especializada en el sector sanitario y farmacéutico, que cotiza en el mercado XKRX. Se centra en el desarrollo de biofármacos innovadores.